Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Angela Carlier, Didi Rhebergen, Frank Schilder, Filip Bouckaert, Pascal Sienaert, Robert Veerhuis, Adriaan W. Hoogendoorn, Piet Eikelenboom, Max L. Stek, Annemiek Dols & Eric van Exel. (2021) The pattern of inflammatory markers during electroconvulsive therapy in older depressed patients. The World Journal of Biological Psychiatry 22:10, pages 770-777.
Read now
Read now
Sonani Mindt, Michael Neumaier, Carolin Hoyer, Alexander Sartorius & Laura Kranaster. (2020) Cytokine-mediated cellular immune activation in electroconvulsive therapy: A CSF study in patients with treatment-resistant depression. The World Journal of Biological Psychiatry 21:2, pages 139-147.
Read now
Read now
Articles from other publishers (29)
Ravi Philip Rajkumar. (2023) Cytokines as Predictors of Response to Electroconvulsive Therapy: an Update. Current Behavioral Neuroscience Reports 10:4, pages 99-109.
Crossref
Crossref
Nima Sanadgol, Adib Miraki Feriz, Sabrina F. Lisboa & Sâmia R.L. Joca. (2023) Putative role of glial cells in treatment resistance depression: An updated critical literation review and evaluation of single-nuclei transcriptomics data. Life Sciences, pages 122025.
Crossref
Crossref
Jean-Baptiste Belge, Peter Mulders, Linda Van Diermen, Pascal Sienaert, Bernard Sabbe, Christopher C. Abbott, Indira Tendolkar, Didier Schrijvers & Philip van Eijndhoven. (2023) Reviewing the neurobiology of electroconvulsive therapy on a micro- meso- and macro-level. Progress in Neuro-Psychopharmacology and Biological Psychiatry, pages 110809.
Crossref
Crossref
Aurora Leontina Lombardi, Lucia Manfredi & David Conversi. (2023) How does IL-6 change after combined treatment in MDD patients? A systematic review. Brain, Behavior, & Immunity - Health 27, pages 100579.
Crossref
Crossref
Sheng-Chiang Wang, Jennifer S. Yokoyama, Nian-Sheng Tzeng, Chia-Fen Tsai & Mu-N Liu. 2023.
Jean-Baptiste Belge, Philip van Eijndhoven & Peter C. R. Mulders. 2023.
Ioana-Alexandra Dogaru, Maria Gabriela Puiu, Mirela Manea & Vlad Dionisie. (2022) Current Perspectives on Pharmacological and Non-Pharmacological Interventions for the Inflammatory Mechanism of Unipolar Depression. Brain Sciences 12:10, pages 1403.
Crossref
Crossref
Alexander Sartorius, Sebastian Karl & David Zilles-Wegner. (2022) Hippocampal neuroplasticity, major depression and, not to forget: ECT. Molecular Psychiatry.
Crossref
Crossref
Milagros Rojas, Daniela Ariza, Ángel Ortega, Manuel E. Riaño-Garzón, Mervin Chávez-Castillo, José Luis Pérez, Lorena Cudris-Torres, María Judith Bautista, Oscar Medina-Ortiz, Joselyn Rojas-Quintero & Valmore Bermúdez. (2022) Electroconvulsive Therapy in Psychiatric Disorders: A Narrative Review Exploring Neuroendocrine–Immune Therapeutic Mechanisms and Clinical Implications. International Journal of Molecular Sciences 23:13, pages 6918.
Crossref
Crossref
AmirMohammad Sharafi, Sina Pakkhesal, Ali Fakhari, Nazli Khajehnasiri & Ali Ahmadalipour. (2022) Rapid treatments for depression: Endocannabinoid system as a therapeutic target. Neuroscience & Biobehavioral Reviews 137, pages 104635.
Crossref
Crossref
Helena M. Abelaira, Thayse Rosa, Airam B. de Moura, Natalia M. Andrade, Nicoly S. Martinello, Larissa R. Maciel, Maria Eduarda M. Botelho, Laura A. Borba, Beatriz C. Chede, Camila O. Arent, Larissa Joaquim, Sandra Bonfante, Lucinéia G. Danielski, Talita Tuon, Fabricia Petronilho, João Quevedo & Gislaine Z. Réus. (2022) Combination of electroconvulsive stimulation with ketamine or escitalopram protects the brain against inflammation and oxidative stress induced by maternal deprivation and is critical for associated behaviors in male and female rats. Molecular Neurobiology 59:3, pages 1452-1475.
Crossref
Crossref
Xi Chen, Yifan Chen, Dake Qi & Donghong Cui. (2022) Multifaceted interconnections between macrophage migration inhibitory factor and psychiatric disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 112, pages 110422.
Crossref
Crossref
Charles-Yoland Desfossés, Rossana Peredo, Andréane Chabot, Jean-Philippe Carmel, Pierre-Marc Tremblay, Chantal Mérette, Geneviève Picher, Isabelle Lachance, Simon Patry & Morgane Lemasson. (2021) The Pattern of Change in Depressive Symptoms and Inflammatory Markers After Electroconvulsive Therapy. The Journal of ECT 37:4, pages 291-297.
Crossref
Crossref
Dara Gammon, Catherine Cheng, Anna Volkovinskaia, Glen B. Baker & Serdar M. Dursun. (2021) Clozapine: Why Is It So Uniquely Effective in the Treatment of a Range of Neuropsychiatric Disorders?. Biomolecules 11:7, pages 1030.
Crossref
Crossref
F. Gay, B. Romeo, C. Martelli, A. Benyamina & N. Hamdani. (2021) Cytokines changes associated with electroconvulsive therapy in patients with treatment-resistant depression: a Meta-analysis. Psychiatry Research 297, pages 113735.
Crossref
Crossref
Jan-Baptist Belge, Linda Van Diermen, Bernard Sabbe, Jan Moens, Manuel Morrens, Violette Coppens, Philippe de Timary, Eric Constant, Kristof Vansteelandt, Pascal Sienaert & Didier Schrijvers. (2021) Improvement of psychomotor retardation after electroconvulsive therapy is related to decreased IL-6 levels. Progress in Neuro-Psychopharmacology and Biological Psychiatry 105, pages 110146.
Crossref
Crossref
Alessandra Borsini, Maria Grazia Di Benedetto, Juliette Giacobbe & Carmine M Pariante. (2020) Pro- and Anti-Inflammatory Properties of Interleukin in Vitro: Relevance for Major Depression and Human Hippocampal Neurogenesis. International Journal of Neuropsychopharmacology 23:11, pages 738-750.
Crossref
Crossref
Jennifer L. Kruse, Richard Olmstead, Gerhard Hellemann, Benjamin Wade, Janina Jiang, Megha M. Vasavada, John O. Brooks III, Eliza Congdon, Randall Espinoza, Katherine L. Narr & Michael R. Irwin. (2020) Inflammation and depression treatment response to electroconvulsive therapy: Sex-specific role of interleukin-8. Brain, Behavior, and Immunity 89, pages 59-66.
Crossref
Crossref
Laura Kranaster, Carolin Hoyer, Sonani Mindt, Michael Neumaier, Norbert Müller, Peter Zill, Markus J. Schwarz, Natalie Moll, Beat Lutz, Laura Bindila, Inga Zerr, Matthias Schmitz, Kaj Blennow, Henrik Zetterberg, Dieter Haffner, Maren Leifheit-Nestler, Cagakan Ozbalci & Alexander Sartorius. (2019) The novel seizure quality index for the antidepressant outcome prediction in electroconvulsive therapy: association with biomarkers in the cerebrospinal fluid. European Archives of Psychiatry and Clinical Neuroscience 270:7, pages 911-919.
Crossref
Crossref
Smadar Goldfarb, Nina Fainstein & Tamir Ben-Hur. (2020) Electroconvulsive stimulation attenuates chronic neuroinflammation. JCI Insight 5:17.
Crossref
Crossref
Alexander Karabatsiakis & Carlos Schönfeldt-Lecuona. (2020) Depression, mitochondrial bioenergetics, and electroconvulsive therapy: a new approach towards personalized medicine in psychiatric treatment - a short review and current perspective. Translational Psychiatry 10:1.
Crossref
Crossref
Nicole Moschny, Kirsten Jahn, Hannah Benedictine Maier, Abdul Qayyum Khan, Matthias Ballmaier, Kyra Liepach, Mareike Sack, Thomas Skripuletz, Stefan Bleich, Helge Frieling & Alexandra Neyazi. (2020) Electroconvulsive therapy, changes in immune cell ratios, and their association with seizure quality and clinical outcome in depressed patients. European Neuropsychopharmacology 36, pages 18-28.
Crossref
Crossref
Jan-Baptist Belge, Linda van Diermen, Bernard Sabbe, Paul Parizel, Manuel Morrens, Violette Coppens, Eric Constant, Philippe de Timary, Pascal Sienaert, Didier Schrijvers & Philip van Eijndhoven. (2020) Inflammation, Hippocampal Volume, and Therapeutic Outcome following Electroconvulsive Therapy in Depressive Patients: A Pilot Study. Neuropsychobiology 79:3, pages 222-232.
Crossref
Crossref
Chenghao Yang, Klaas J. Wardenaar, Fokko J. Bosker, Jie Li & Robert A. Schoevers. (2019) Inflammatory markers and treatment outcome in treatment resistant depression: A systematic review. Journal of Affective Disorders 257, pages 640-649.
Crossref
Crossref
Angela Carlier, Johanna G. Berkhof, Maarten Rozing, Filip Bouckaert, Pascal Sienaert, Piet Eikelenboom, Robert Veerhuis, Mathieu Vandenbulcke, Johannes Berkhof, Max L. Stek, Didi Rhebergen, Annemiek Dols & Eric van Exel. (2019) Inflammation and remission in older patients with depression treated with electroconvulsive therapy; findings from the MODECT study✰. Journal of Affective Disorders 256, pages 509-516.
Crossref
Crossref
Tore Ivar Aarsland, Ieva Leskauskaite, Øivind Midttun, Arve Ulvik, Per Magne Ueland, Leif Oltedal, Vera Jane Erchinger, Ketil Joachim Oedegaard, Jan Haavik & Ute Kessler. (2019) The effect of electroconvulsive therapy (ECT) on serum tryptophan metabolites. Brain Stimulation 12:5, pages 1135-1142.
Crossref
Crossref
Norbert Müller, Daniela Krause, Rike Barth, Aye-Mu Myint, Elif Weidinger, Waltraud Stettinger, Peter Zill, Hemmo Drexhage & Markus J. Schwarz. (2019) Childhood Adversity and Current Stress are related to Pro- and Anti-inflammatory Cytokines in Major Depression. Journal of Affective Disorders 253, pages 270-276.
Crossref
Crossref
Laura Kranaster, Kaj Blennow, Henrik Zetterberg & Alexander Sartorius. (2019) Reduced vascular endothelial growth factor levels in the cerebrospinal fluid in patients with treatment resistant major depression and the effects of electroconvulsive therapy—A pilot study. Journal of Affective Disorders 253, pages 449-453.
Crossref
Crossref
Laura Kranaster, Kaj Blennow, Henrik Zetterberg & Alexander Sartorius. (2017) Electroconvulsive therapy does not alter the synaptic protein neurogranin in the cerebrospinal fluid of patients with major depression. Journal of Neural Transmission 124:12, pages 1641-1645.
Crossref
Crossref